The concentration of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in peripheral venous plasma throughout the normal ovarian and menstrual cycle
- PMID: 7355661
- DOI: 10.1530/acta.0.0930123
The concentration of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in peripheral venous plasma throughout the normal ovarian and menstrual cycle
Abstract
The concentration of 13,14-dihydro-15-oxo-prostaglandin F2 alpha (PGFM) has been measured in daily samples of peripheral venous plasma from 5 women throughout the ovarian or menstrual cycle. The values have been combined by days, relative to a pre-ovulatory peak, the LH peak and to Day 1 of the next menstrual cycle. The patterns (geometric means) have been related to the corresponding values for oestradiol, LH and progesterone. The results show that there was considerable variation in the concentration of PGFM (50-909 pmol/l; n = 140) and that the coefficient of variation within an individual cycle ranged from 30-74%. Nevertheless two peaks--one pre-ovulatory (associated with a marked increase in the level of circulating oestradiol) and one pre-menstrual (associated with rapidly falling levels of circulating oestradiol and progesterone) were apparent in all cycles. The concentration of PGFM during the pre-ovulatory rise was 521 +/- 325 pmol/l; mean +/- SD and the corresponding value for the pre-menstrual rise was 571 +/- 325; both peaks were significantly higher (P less than 0.0025, P less than 0.0005, respectively, Student's t-test) than during the remainder of the cycle (257 +/- 190). There was no significant difference, however, between the concentration during the follicular and luteal phases.
Similar articles
-
Radioimmunoassay for 13, 14-dihydro-15-ketoprostaglandin F2 alpha and its application in normo- and anovulatory women.Acta Endocrinol (Copenh). 1982 May;100(1):98-104. doi: 10.1530/acta.0.1000098. Acta Endocrinol (Copenh). 1982. PMID: 6810612
-
Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.J Endocrinol. 1987 Nov;115(2):355-61. doi: 10.1677/joe.0.1150355. J Endocrinol. 1987. PMID: 3125302
-
Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.J Endocrinol. 1975 Jan;64(1):37-47. doi: 10.1677/joe.0.0640037. J Endocrinol. 1975. PMID: 1167896
-
Plasma concentrations of progesterone, oestradiol-17 beta and 13,14-dihydro-15-oxo-prostaglandin F2 alpha in the pregnant wallaby (Macropus rufogriseus rufogriseus).J Endocrinol. 1983 Jun;97(3):369-77. doi: 10.1677/joe.0.0970369. J Endocrinol. 1983. PMID: 6864145
-
Ovulation detection in the human.Clin Reprod Fertil. 1982 Mar;1(1):27-54. Clin Reprod Fertil. 1982. PMID: 6821195 Review.
Cited by
-
Short-term GnRH-analogue administration in patients with PCOS and its impact on hemodynamics and hormonal profile.J Assist Reprod Genet. 1997 Nov;14(10):558-61. doi: 10.1023/a:1022520415915. J Assist Reprod Genet. 1997. PMID: 9447454 Free PMC article.
-
Do exogenous oestrogens and progesterone influence asthma?Thorax. 1999 Mar;54(3):265-7. doi: 10.1136/thx.54.3.265. Thorax. 1999. PMID: 10325904 Free PMC article. Review. No abstract available.
-
Premenstrual asthma: epidemiology, pathogenesis and treatment.Drugs. 2001;61(14):2079-86. doi: 10.2165/00003495-200161140-00005. Drugs. 2001. PMID: 11735634 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous